Online Program

281668
Complementary and alternative medicine use in overweight and obese cancer patients with comorbidities


Monday, November 4, 2013

Mary Ojukwu, BS, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, Rockville, MD
Justice Mbizo, MS. Dr.PH, Department of Public Health, The University of West Florida, Pensacola, FL
Farah Zia, M.D., Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, Rockville, MD
Oluwadamilola Olaku, MD, MPH, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, Rockville, MD
OBJECTIVE: Increasing rates of complementary and alternative medicine (CAM) use by cancer patients coincide with the increasing rates of obesity in the US. To our knowledge, our study is the first to describe CAM use for the overweight and obese cancer population living with and without other chronic co-morbidities. METHODOLOGY: Data for 1,785 adult Americans with a history of cancer were obtained from the 2007 National Health Interview Survey (NHIS) and CAM supplement. The outcome of interest was the frequency of CAM use within the overweight, obese, and normal weight cancer population. Data were weighted and analyzed using Stata software version 12 for Windows. In addition to descriptive and bi-variate statistics, multivariate logistic regression was performed to estimate the odds of CAM use by selected covariates. RESULTS: The average age of the respondents was 63 (SD 15.2 ) years and 56.4% were female. Sixty percent were overweight or obese. About 89 percent of the respondents used CAM. Respondents who are female (OR: 2.6; p=0.000), overweight (OR: 1.9; p=0.007), and in the western region of U.S. are more likely to use CAM (OR: 2.7; p=0.009). The presence of co-morbidity did not alter CAM use within the overweight or obese cancer population. In contrast to previous findings in the literature, income, education, and health insurance coverage were not significant predictors of CAM use. CONCLUSION: Overweight cancer patients were more likely to use CAM. There was no difference in CAM use within the overweight and obese cancer patients with or without co-morbidity.

Learning Areas:

Epidemiology
Public health or related research

Learning Objectives:
Identify the correlates of complementary and alternative medicine use in the overweight and obese United States adult population. Evaluate how chronic conditions affect complementary and alternative medicine use in obese and overweight cancer population.

Keyword(s): Cancer, Obesity

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have am a trainee of the National Cancer Institute's Cancer Research Training award. The training here has allowed me to pursue research related to complementary and alternative medicine through the Office of Cancer Complementary and Alternative Medicine.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.